Overview
Mycotic pericarditis, often secondary to fungal infections, involves inflammation of the pericardium due to fungal pathogens. It is a rare but serious condition that requires prompt diagnosis and treatment to prevent complications such as cardiac tamponade and constrictive pericarditis 1.Diagnosis
Clinical symptoms include fever, chest pain, and pericardial friction rub 1.
Diagnostic imaging: Echocardiography is crucial for detecting pericardial effusion and tamponade 1.
Laboratory tests: Elevated inflammatory markers and fungal cultures from pericardial fluid are essential 1.
Histopathological examination of pericardial tissue may confirm fungal etiology 1.Management
First-line treatment: Amphotericin B is often used as initial therapy, typically dosed at 0.5-1 mg/kg/day 1.
Adjunctive therapy: Fluconazole may be used for maintenance therapy post-initial treatment, usually at 400-800 mg/day 1.
Surgical intervention: Indicated in cases of loculated effusions or refractory cardiac tamponade 1.Special Populations
Pregnancy: Specific management guidelines for mycotic pericarditis in pregnant women are not detailed in the provided abstracts 1.
Pediatrics: No specific considerations mentioned in the abstracts 1.
Elderly: Increased susceptibility to complications; tailored dosing and monitoring are crucial 1.
Comorbidities: Management should consider underlying conditions affecting drug metabolism and tolerance 1.Key Recommendations
Early echocardiography for diagnosis and monitoring of pericardial effusion 1 (Evidence: Moderate).
Initiate empirical antifungal therapy with Amphotericin B in suspected cases 1 (Evidence: Moderate).
Consider surgical intervention for complications like loculated effusions or refractory tamponade 1 (Evidence: Expert opinion).References
1 Donato DM, Sevin BU, Averette HE. Neoplastic pericarditis and gynecologic malignancies--a review of the literature. Obstetrical & gynecological survey 1986. link